Cytori Therapeutics, Inc. Provides Business Update Along With Top-Line Unaudited 2014 Financial Results At The Cowen and Company 35th Annual Health Care Conference In Boston

04 Mar 2015

·www.biospace.com

Financial Statement

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) today provided a business and financial performance update in its presentation at the Cowen and Company 35th Annual Health Care Conference in Boston today. The corporate presentation includes certain top-line preliminary unaudited financial results for the quarter and full year ended December 31, 2014 and select performance guidance for the full-year 2015. Help employers find you! Check out all the jobs and post your resume.

Organizations

Cytori Ltd.Cytori Therapeutics, Inc. (JP)

Indications

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.